Scorpion Therapeutics

Scorpion Therapeutics

Biotechnology Research 35 employees
Employees
35
Contacts
3
Emails
3
Phones
1

Scorpion Therapeutics Overview

Phone Number
Available in AeroLeads
Website
scorpiontx.com
Industry
Biotechnology Research
Employees
35
Founded
2020
Funding
150.0M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Scorpion Therapeutics

Scorpion is a clinical-stage, precision oncology company developing transformational targeted therapies for patients with cancer. We have built proprietary and fully-integrated discovery capabilities leveraging the most advanced technologies across cancer biology, medicinal chemistry and data sciences. Our current pipeline, led by our mutant-selective PI3Ka program STX-478, consists of three internally discovered clinical product candidates in addition to multiple discovery-stage programs. Our focus is on solving current gaps in therapeutic options for patients with cancer by discovering and developing exquisitely-selective product candidates against well-validated, previously undruggable targets to improve patient outcomes.

Scorpion Therapeutics Contact Details

People in AeroLeads
4
With contact data
3
Email contacts
3
75.0% coverage
Phone contacts
1
25.0% coverage

Scorpion Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Emily Anderson Vice President, Communications
Email Phone
Ming Lin
Email
Amanda S. Biotech Executive - Program
Email
Brian Piper Chief Financial Officer at Scorpion
View

Employees by Management Level

Manager 6 profiles
Individual contributor 5 profiles
Senior / Lead 4 profiles
Executive 3 profiles
Associate / junior 2 profiles
Director 1 profile
Intern / trainee 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 4 4 0
Marketing 1 1 1
Executive 1 1 1
Healthcare 1 1 0

Scorpion Therapeutics Tech Stack

Data / AI 6 profiles

Compare Similar Companies to Scorpion Therapeutics